首页> 美国卫生研究院文献>Frontiers in Neuroengineering >Development of Micro-Electrode Array Based Tests for Neurotoxicity: Assessment of Interlaboratory Reproducibility with Neuroactive Chemicals
【2h】

Development of Micro-Electrode Array Based Tests for Neurotoxicity: Assessment of Interlaboratory Reproducibility with Neuroactive Chemicals

机译:基于微电极阵列的神经毒性测试方法的开发:用神经活性化学品评估实验室间的可重复性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuronal assemblies within the nervous system produce electrical activity that can be recorded in terms of action potential patterns. Such patterns provide a sensitive endpoint to detect effects of a variety of chemical and physical perturbations. They are a function of synaptic changes and do not necessarily involve structural alterations. In vitro neuronal networks (NNs) grown on micro-electrode arrays (MEAs) respond to neuroactive substances as well as the in vivo brain. As such, they constitute a valuable tool for investigating changes in the electrophysiological activity of the neurons in response to chemical exposures. However, the reproducibility of NN responses to chemical exposure has not been systematically documented. To this purpose six independent laboratories (in Europe and in USA) evaluated the response to the same pharmacological compounds (Fluoxetine, Muscimol, and Verapamil) in primary neuronal cultures. Common standardization principles and acceptance criteria for the quality of the cultures have been established to compare the obtained results. These studies involved more than 100 experiments before the final conclusions have been drawn that MEA technology has a potential for standard in vitro neurotoxicityeuropharmacology evaluation. The obtained results show good intra- and inter-laboratory reproducibility of the responses. The consistent inhibitory effects of the compounds were observed in all the laboratories with the 50% Inhibiting Concentrations (IC50s) ranging from: (mean ± SEM, in μM) 1.53 ± 0.17 to 5.4 ± 0.7 (n = 35) for Fluoxetine, 0.16 ± 0.03 to 0.38 ± 0.16 μM (n = 35) for Muscimol, and 2.68 ± 0.32 to 5.23 ± 1.7 (n = 32) for Verapamil. The outcome of this study indicates that the MEA approach is a robust tool leading to reproducible results. The future direction will be to extend the set of testing compounds and to propose the MEA approach as a standard screen for identification and prioritization of chemicals with neurotoxicity potential.
机译:神经系统内的神经元组件产生的电活动可以按照动作电位模式进行记录。这样的模式提供了一个敏感的终点来检测各种化学和物理扰动的影响。它们是突触变化的功能,并不一定涉及结构改变。在微电极阵列(MEA)上生长的体外神经元网络(NN)对神经活性物质以及体内大脑也有反应。这样,它们构成了一种有价值的工具,用于研究响应化学暴露的神经元电生理活动的变化。但是,尚未系统记录NN对化学暴露的可重复性。为此,六个独立的实验室(在欧洲和美国)评估了原代神经元培养物中对相同药理化合物(氟西汀,麝香酚和维拉帕米)的反应。建立了通用的文化质量标准化原则和接受标准,以比较所获得的结果。这些研究涉及100多个实验,最后得出的结论是MEA技术具有进行标准的体外神经毒性/神经药理学评估的潜力。获得的结果显示了实验室间和实验室间反应的良好再现性。在所有实验室中均观察到了化合物的一致抑制作用,其50%抑制浓度(IC50)为:(平均值±SEM),以μM为单位:1.53±ox0.17至5.4±0.7(n = 35),氟西汀,0.16± Muscimol为0.03至0.38±0.16μM(n = 35),维拉帕米为2.68±0.32至5.23±1.7(n = 32)。这项研究的结果表明,MEA方法是导致可重复结果的可靠工具。未来的方向将是扩展测试化合物的范围,并建议将MEA方法作为鉴定和确定具有神经毒性潜力的化学品的优先顺序的标准筛选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号